Perfluoroalkyl substances and thyroid hormones in cord blood

2017 ◽  
Vol 222 ◽  
pp. 543-548 ◽  
Author(s):  
Meng-Shan Tsai ◽  
Ching-Chun Lin ◽  
Mei-Huei Chen ◽  
Wu-Shiun Hsieh ◽  
Pau-Chung Chen
2016 ◽  
Vol 2016 (1) ◽  
Author(s):  
Meng-Shan Tsai* ◽  
Ching-Chun Lin ◽  
Mei-Huei Chen ◽  
Wu-Shiun Hsieh ◽  
Pau-Chung Chen

2020 ◽  
Vol 19 (1) ◽  
Author(s):  
Hong Liang ◽  
Ziliang Wang ◽  
Maohua Miao ◽  
Youping Tian ◽  
Yan Zhou ◽  
...  

Abstract Background Evidence of associations between prenatal exposure to perfluoroalkyl substances (PFASs) and fetal thyroid hormones (THs) is controversial, and few studies have estimated the associations, while addressing the high correlations among multiple PFASs. We aimed to examine the associations between prenatal PFAS exposure and thyroid hormone concentrations in cord blood. Methods A total of 300 mother-infant pairs from the Shanghai-Minhang Birth Cohort Study were included. We measured the concentrations of eight PFASs in maternal plasma samples collected at 12–16 gestational weeks, as well as those of total thyroxine (T4), free T4 (FT4), total triiodothyronine (T3), free T3 (FT3), and thyroid stimulating hormone (TSH) in cord plasma. We estimated the associations between maternal PFAS concentrations and TH concentrations using linear regression and Bayesian kernel machine regression (BKMR) models. Results In BKMR models, higher PFAS mixture concentrations were associated with increased T3 concentrations, and there were suggestive associations with increased FT3 concentrations. For single-exposure effects in BKMR models, a change in PFDA, PFUdA, and PFOA concentrations from the 25th to 75th percentile was associated with a 0.04 (95%CrI: − 0.01, 0.09), 0.02 (95%CrI: − 0.03, 0.07), and 0.03 (95%CrI: − 0.001, 0.06) nmol/L increase in T3 concentrations, respectively. PFOA, PFNA, and PFDA were the predominant compounds in PFASs-FT3 associations, and the corresponding estimates were 0.11 (95% CrI: 0.02, 0.19), − 0.17 (95% CrI: − 0.28, − 0.07), and 0.12 (95% CrI: − 0.004, 0.24) pmol/L, respectively. A change in PFNA and PFOA concentrations from the 25th to 75th percentile was associated with a − 1.69 (95% CrI: − 2.98, − 0.41) μIU/mL decrease and a 1.51 (95% CrI: 0.48, 2.55) μIU/mL increase in TSH concentrations. The associations of PFOA and PFNA with T3/FT3 were more pronounced in boys, while those with TSH were more pronounced in girls. Conclusion Our results suggest that prenatal exposure to multiple PFASs was associated with thyroid hormones in cord blood. However, individual PFAS had varied effects—differing in magnitude and direction—on fetal thyroid hormones.


Author(s):  
Blanca Sarzo ◽  
Virginia Ballesteros ◽  
Carmen Iñiguez ◽  
Cyntia B. Manzano-Salgado ◽  
Maribel Casas ◽  
...  

2016 ◽  
Vol 6 (1) ◽  
Author(s):  
Lin Yang ◽  
Jingguang Li ◽  
Jianqiang Lai ◽  
Hemi Luan ◽  
Zongwei Cai ◽  
...  

2015 ◽  
Vol 6 (1) ◽  
pp. 17
Author(s):  
Parinaz Poursafa ◽  
Ashraf Javidi ◽  
Nasim Rafiei ◽  
MohammadMehdi Amin ◽  
Silva Hovsepian ◽  
...  

1988 ◽  
Vol 34 (11) ◽  
pp. 2371-2371 ◽  
Author(s):  
D A Orinda ◽  
M Braddick ◽  
J Meme ◽  
J O Achola ◽  
P Achola
Keyword(s):  

2015 ◽  
Vol 77 ◽  
pp. 63-69 ◽  
Author(s):  
Vivian Berg ◽  
Therese Haugdahl Nøst ◽  
Solrunn Hansen ◽  
Astrid Elverland ◽  
Anna-Sofía Veyhe ◽  
...  

2020 ◽  
Vol 33 (7-8) ◽  
pp. 483
Author(s):  
Inês Romão Luz ◽  
João Rio Martins ◽  
Mónica Jerónimo ◽  
Joana Serra Caetano ◽  
Rita Cardoso ◽  
...  

Introduction: Graves disease is characterized by the existence of autoantibodies directed to the thyrotropin receptor, which can have a stimulatory/inhibitory action, in women with the condition, their fetus or neonate. Our aim was to review the case series of these neonates in order to establish neonatal thyroid function predictors.Material and Methods: Retrospective cohort study of the database of the Department of Pediatric Endocrinology, including patients born to mothers with Graves’ disease, between 2002 and 2017. Clinical and biochemical data were collected from mothers and offspring.Results: Fifty newborns, from 46 women with a median of 3.5 years after diagnosis, were included. During all trimesters of pregnancy, more than half of women had positive autoantibodies directed to the thyrotropin receptor. Not every woman had a complete thyroid function evaluation every trimester. In 32 newborns, cord blood screening was done. During the neonatal period, there were three cases of hypothyroidism and two of hyperthyroidism. The mothers of these five newborns had higher levels of free thyroid hormones during the second trimester (p = 0.03). The level of antibodies directed to the thyrotropin receptor was significantly higher in the cord blood (p = 0.03) and in the first neonatal test (p = 0.03) of these dysthyroid newborns.Discussion: Our results reinforce the need for every pregnant woman with Graves’ disease to be subject to thyroid function and autoantibodies evaluation during every trimester, as well as the importance of evaluating these antibodies in cord blood.Conclusion: High levels of free thyroid hormones during the second trimester of pregnancy and antibodies directed to the thyrotropin receptor value in cord blood are predictors of dysthyroidism in neonates born from women with Grave’s disease.


2011 ◽  
Vol 214 (2) ◽  
pp. 115-120 ◽  
Author(s):  
Shu-Ming Lin ◽  
Fu-An Chen ◽  
Ya-Fang Huang ◽  
Liang-Lan Hsing ◽  
Ling-Ling Chen ◽  
...  
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document